FINANCIAL IMPLICATIONS TO MEDICARE FROM CHANGING THE DIALYSIS MODALITY MIX UNDER THE BUNDLED PROSPECTIVE PAYMENT SYSTEM

摘要

Background: The economic burden of treating end-stage renal disease (ESRD) continues to grow. As one response, effective January 1, 2011, Medicare implemented a bundled prospective payment system (PPS, including injectable drugs) for dialysis patients. This study investigated the 5-year budget impact on Medicare under the new PPS of changes in the distribution of patients undergoing peritoneal dialysis (PD), in-center hemodialysis (ICHD), and home hemodialysis (HHD).